Compounds > meglumine antimoniate
Page last updated: 2024-08-24

meglumine antimoniate and Chromosome-Defective Micronuclei

meglumine antimoniate has been researched along with Chromosome-Defective Micronuclei in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almeida, LP; Cantanhêde, LF; Castelo Branco, PV; Pereira, SR; Soares, RE1
Alves, EV; Arruda, VO; de Azevedo, AP; Lima, MI; Monteiro, SG; Pereira, SR1

Other Studies

2 other study(ies) available for meglumine antimoniate and Chromosome-Defective Micronuclei

ArticleYear
Soy isoflavones have antimutagenic activity on DNA damage induced by the antileishmanial Glucantime (meglumine antimoniate).
    Drug and chemical toxicology, 2015, Volume: 38, Issue:3

    Topics: Animals; Antimutagenic Agents; Antioxidants; Antiprotozoal Agents; Comet Assay; DNA Damage; Female; Glycine max; Isoflavones; Male; Meglumine; Meglumine Antimoniate; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutation; Organometallic Compounds; Oxidative Stress

2015
Genotoxic effects of the antileishmanial drug Glucantime.
    Archives of toxicology, 2010, Volume: 84, Issue:3

    Topics: Animals; Antimony; Apoptosis; Bone Marrow Cells; Cells, Cultured; Comet Assay; DNA; DNA Damage; Female; Humans; Lymphocytes; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Organometallic Compounds; Oxidation-Reduction; Trypanocidal Agents

2010